Trial Profile
Safety of anacetrapib and moxifloxacin in healthy young subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Anacetrapib (Primary) ; Moxifloxacin
- Indications Atherosclerosis; Hypercholesterolaemia; Hyperlipidaemia; Hyperlipoproteinaemia type IIa
- Focus Adverse reactions; Pharmacokinetics
- 03 Dec 2015 New trial record
- 23 Oct 2015 Results published in the Vaccine